Arcus Biosciences (RCUS) Asset Utilization Ratio (2018 - 2026)

Arcus Biosciences' Asset Utilization Ratio history runs 9 years deep, the most recent figure standing at 0.22 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio rose 84.14% year-over-year to 0.22; the TTM figure through Mar 2026 stood at 0.22 (up 84.14% YoY), while the FY2025 annual figure was 0.22, down 6.1% from the prior year.
• Asset Utilization Ratio was 0.22 for Q1 2026 at Arcus Biosciences, down from 0.23 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.3 in Q3 2022 to a low of 0.08 in Q4 2022.
• Historically, Asset Utilization Ratio has averaged 0.18 across 5 years, with a median of 0.2 in 2024.
• Biggest YoY gain for Asset Utilization Ratio was 591.67% in 2022; the steepest drop was 73.61% in 2022.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.08 in 2022, then rose by 5.21% to 0.09 in 2023, then soared by 140.73% to 0.21 in 2024, then advanced by 11.01% to 0.23 in 2025, then retreated by 5.48% to 0.22 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.22 (Q1 2026), 0.23 (Q4 2025), and 0.23 (Q3 2025), per Business Quant data.